Validity of the Stent Thrombosis Risk Score in Predicting Early Stent Thrombosis After Primary Percutaneous Coronary Intervention

Overview

Journal J Saudi Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2020 Nov 6

PMID 33154926

Citations 1

Authors

Rajesh Kumar

Sahar Tariq

Madiha Fatima

Tahir Saghir

Mahesh Kumar Batra

Musa Karim

Jawaid Akbar Sial

Naveedullah Khan

Syed Nadeem Hasan Rizvi

Affiliations

Soon will be listed here.

Abstract

Background: The thrombosis of the stent is one of the most important complications of percutaneous interventions, resulting in complete occlusion of the stented vessel. Aim of this study was to determine the validity of Stent Thrombosis Risk Score (STRS) in predicting early stent thrombosis (ST) after primary Percutaneous Coronary Intervention (PCI).

Methods: For this study, 569 consecutive patients undergone primary PCI from July 2018 to December 2018 were recruited. Early ST was defined as ST occurred during or within 30 days after the procedure. The STRS was calculated as proposed, developed, and validated in a past study. The receiver operating characteristic curve analysis was performed to determine the optimal cut-off value and area under the curve (AUC).

Results: A total of 569 patients were included, the median age was 56 [61-50] years. Early ST was observed in 33 (5.8%) patients. The median STRS was 4 [5-3] vs. 3 [4-2]; p = 0.009 for patients with and without Early ST respectively. STRS was found to be an independent predictor of early ST with an adjusted odds ratio of 1.41 (1.02-1.95). AUC was 0.631 and the optimal cut-off value was ≥5. Early ST rate was 3.3% at STRS of 0-2, which raised to 5.0% at STR of 3-4, and 17.2% at STRS of ≥5.

Conclusions: In conclusion, STRS was found to be an independent predictor of early ST after primary PCI and has significant discriminating power. The rate of early stent thrombosis after primary PCI exponentially increased at STRS cut-off value of ≥5.

Citing Articles

Anghel L, Tudurachi B, Tudurachi A, Zavoi A, Clement A, Roungos A J Clin Med. 2023; 12(23).

PMID: 38068419 PMC: 10707589. DOI: 10.3390/jcm12237367.

References

Buchanan G, Basavarajaiah S, Chieffo A . Stent thrombosis: incidence, predictors and new technologies. Thrombosis. 2012; 2012:956962. PMC: 3329679. DOI: 10.1155/2012/956962. View

Brodie B, Pokharel Y, Garg A, Kissling G, Hansen C, Milks S . Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2012; 5(10):1043-51. DOI: 10.1016/j.jcin.2012.06.013. View

Luscher T . Epidemiology of cardiovascular disease: the new ESC Atlas and beyond. Eur Heart J. 2018; 39(7):489-492. DOI: 10.1093/eurheartj/ehy070. View

Lasala J, Cox D, Dobies D, Baran K, Bachinsky W, Rogers E . Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Circ Cardiovasc Interv. 2009; 2(4):285-93. DOI: 10.1161/CIRCINTERVENTIONS.109.852178.109.852178. View

Garcia-Garcia H, McFadden E, Farb A, Mehran R, Stone G, Spertus J . Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document. Eur Heart J. 2018; 39(23):2192-2207. DOI: 10.1093/eurheartj/ehy223. View

Rosillo S, Lopez-de-Sa E, Iniesta A, de Torres F, Del Prado S, Rey J . Is therapeutic hypothermia a risk factor for stent thrombosis?. J Am Coll Cardiol. 2013; 63(9):939-40. DOI: 10.1016/j.jacc.2013.09.028. View

Laarman G, Suttorp M, Dirksen M, van Heerebeek L, Kiemeneij F, Slagboom T . Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006; 355(11):1105-13. DOI: 10.1056/NEJMoa062598. View

Song L, Guan C, Yan H, Qiao S, Wu Y, Yuan J . Validation of contemporary risk scores in predicting coronary thrombotic events and major bleeding in patients with acute coronary syndrome after drug-eluting stent implantations. Catheter Cardiovasc Interv. 2018; 91(S1):573-581. DOI: 10.1002/ccd.27468. View

Tariq S, Kumar R, Fatima M, Saghir T, Masood S, Karim M . Acute and sub-acute stent thrombosis: Frequency, predictors and features in patients undergoing primary percutaneous intervention at a tertiary care cardiac centre. Int J Cardiol Heart Vasc. 2019; 26:100427. PMC: 6864178. DOI: 10.1016/j.ijcha.2019.100427. View

10.

Ambrose J, Winters S, Stern A, Eng A, Teichholz L, Gorlin R . Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985; 5(3):609-16. DOI: 10.1016/s0735-1097(85)80384-3. View

11.

Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi G, Stankovic G . Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293(17):2126-30. DOI: 10.1001/jama.293.17.2126. View

12.

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

13.

Brugaletta S, Sabate M, Martin-Yuste V, Masotti M, Shiratori Y, Alvarez-Contreras L . Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial. Int J Cardiol. 2013; 168(3):2632-6. DOI: 10.1016/j.ijcard.2013.03.036. View

14.

Stone G, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Dudek D . Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008; 358(21):2218-30. DOI: 10.1056/NEJMoa0708191. View

15.

Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys P . The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc Interv. 2009; 2(6):534-41. DOI: 10.1016/j.jcin.2009.04.003. View

16.

Dangas G, Caixeta A, Mehran R, Parise H, Lansky A, Cristea E . Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation. 2011; 123(16):1745-56. DOI: 10.1161/CIRCULATIONAHA.110.981688. View

17.

Dangas G, Claessen B, Mehran R, Xu K, Fahy M, Parise H . Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012; 5(11):1097-105. DOI: 10.1016/j.jcin.2012.07.012. View

18.

van Werkum J, Heestermans A, Zomer A, Kelder J, Suttorp M, Rensing B . Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009; 53(16):1399-409. DOI: 10.1016/j.jacc.2008.12.055. View

19.

Stone G, Bertrand M, Colombo A, Dangas G, Farkouh M, Feit F . Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. Am Heart J. 2004; 148(5):764-75. DOI: 10.1016/j.ahj.2004.04.036. View